What is the Market's View on Impel Pharmaceuticals Inc (IMPL) Stock's Price and Volume Trends Friday?

Friday, November 24, 2023 01:13 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Impel Pharmaceuticals Inc (IMPL) Stock's Price and Volume Trends Friday?

The market has been high on Impel Pharmaceuticals Inc (IMPL) stock recently. IMPL gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Impel Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IMPL!

See Full IMPL Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With IMPL Stock Today?

Impel Pharmaceuticals Inc (IMPL) stock is trading at $0.84 as of 1:05 PM on Friday, Nov 24, an increase of $0.07, or 8.41% from the previous closing price of $0.78. The stock has traded between $0.50 and $0.95 so far today. Volume today is high. So far 6,404,792 shares have traded compared to average volume of 1,452,922 shares.

More About Impel Pharmaceuticals Inc

Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations. Click Here to get the full Stock Report for Impel Pharmaceuticals Inc stock.